These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 9615758

  • 21. Differences in expression of pro-caspases in small cell and non-small cell lung carcinoma.
    Joseph B, Ekedahl J, Sirzen F, Lewensohn R, Zhivotovsky B.
    Biochem Biophys Res Commun; 1999 Aug 27; 262(2):381-7. PubMed ID: 10462484
    [Abstract] [Full Text] [Related]

  • 22. Reduction in BCL-2 levels by 26S proteasome inhibition with bortezomib is associated with induction of apoptosis in small cell lung cancer.
    Mortenson MM, Schlieman MG, Virudachalam S, Lara PN, Gandara DG, Davies AM, Bold RJ.
    Lung Cancer; 2005 Aug 27; 49(2):163-70. PubMed ID: 16022909
    [Abstract] [Full Text] [Related]

  • 23. Small cell lung carcinoma exhibits greater phospholipase C-beta1 expression and edelfosine resistance compared with non-small cell lung carcinoma.
    Strassheim D, Shafer SH, Phelps SH, Williams CL.
    Cancer Res; 2000 May 15; 60(10):2730-6. PubMed ID: 10825148
    [Abstract] [Full Text] [Related]

  • 24. Imatinib mesylate efficiently achieves therapeutic intratumor concentrations in vivo but has limited activity in a xenograft model of small cell lung cancer.
    Wolff NC, Randle DE, Egorin MJ, Minna JD, Ilaria RL.
    Clin Cancer Res; 2004 May 15; 10(10):3528-34. PubMed ID: 15161712
    [Abstract] [Full Text] [Related]

  • 25. 3-(Iodoacetamido)-benzoylurea: a novel cancericidal tubulin ligand that inhibits microtubule polymerization, phosphorylates bcl-2, and induces apoptosis in tumor cells.
    Jiang JD, Davis AS, Middleton K, Ling YH, Perez-Soler R, Holland JF, Bekesi JG.
    Cancer Res; 1998 Dec 01; 58(23):5389-95. PubMed ID: 9850070
    [Abstract] [Full Text] [Related]

  • 26. Modulation of cIAP-1 by novel antitubulin agents when combined with bryostatin 1 results in increased apoptosis in the human early pre-B acute lymphoblastic leukemia cell line Reh.
    Wall NR, Mohammad RM, Nabha SM, Pettit GR, Al-Katib AM.
    Biochem Biophys Res Commun; 1999 Dec 09; 266(1):76-80. PubMed ID: 10581168
    [Abstract] [Full Text] [Related]

  • 27. M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion.
    Song P, Sekhon HS, Lu A, Arredondo J, Sauer D, Gravett C, Mark GP, Grando SA, Spindel ER.
    Cancer Res; 2007 Apr 15; 67(8):3936-44. PubMed ID: 17440109
    [Abstract] [Full Text] [Related]

  • 28. Ritterazine B, a new cytotoxic natural compound, induces apoptosis in cancer cells.
    Komiya T, Fusetani N, Matsunaga S, Kubo A, Kaye FJ, Kelley MJ, Tamura K, Yoshida M, Fukuoka M, Nakagawa K.
    Cancer Chemother Pharmacol; 2003 Mar 15; 51(3):202-8. PubMed ID: 12655437
    [Abstract] [Full Text] [Related]

  • 29. Retinoblastoma tumor suppressor gene expression determines the response to sequential flavopiridol and doxorubicin treatment in small-cell lung carcinoma.
    Budak-Alpdogan T, Chen B, Warrier A, Medina DJ, Moore D, Bertino JR.
    Clin Cancer Res; 2009 Feb 15; 15(4):1232-40. PubMed ID: 19174488
    [Abstract] [Full Text] [Related]

  • 30. Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells.
    Ikuta K, Takemura K, Kihara M, Naito S, Lee E, Shimizu E, Yamauchi A.
    Oncol Rep; 2005 Jun 15; 13(6):1229-34. PubMed ID: 15870947
    [Abstract] [Full Text] [Related]

  • 31. Structure-activity relationship studies of ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (HA 14-1), an antagonist for antiapoptotic Bcl-2 proteins to overcome drug resistance in cancer.
    Doshi JM, Tian D, Xing C.
    J Med Chem; 2006 Dec 28; 49(26):7731-9. PubMed ID: 17181155
    [Abstract] [Full Text] [Related]

  • 32. Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53.
    Mathiasen IS, Lademann U, Jäättelä M.
    Cancer Res; 1999 Oct 01; 59(19):4848-56. PubMed ID: 10519395
    [Abstract] [Full Text] [Related]

  • 33. Targeting gastrin-releasing peptide receptors on small cell lung cancer cells with a bispecific molecule that activates polyclonal T lymphocytes.
    Zhou J, Chen J, Zhong R, Mokotoff M, Shultz LD, Ball ED.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2224-31. PubMed ID: 16609038
    [Abstract] [Full Text] [Related]

  • 34. Serine-70 is one of the critical sites for drug-induced Bcl2 phosphorylation in cancer cells.
    Haldar S, Basu A, Croce CM.
    Cancer Res; 1998 Apr 15; 58(8):1609-15. PubMed ID: 9563469
    [Abstract] [Full Text] [Related]

  • 35. Quinolone analogue inhibits tubulin polymerization and induces apoptosis via Cdk1-involved signaling pathways.
    Chen YC, Lu PH, Pan SL, Teng CM, Kuo SC, Lin TP, Ho YF, Huang YC, Guh JH.
    Biochem Pharmacol; 2007 Jun 30; 74(1):10-9. PubMed ID: 17475221
    [Abstract] [Full Text] [Related]

  • 36. Benzamide riboside induced mitochondrial mediated apoptosis in human lung cancer H520 cells.
    Khanna N, Jayaram HN, Singh N.
    Life Sci; 2004 May 28; 75(2):179-90. PubMed ID: 15120570
    [Abstract] [Full Text] [Related]

  • 37. Bcl-2 expression as a predictor of chemosensitivities and survival in small cell lung cancer.
    Takayama K, Ogata K, Nakanishi Y, Yatsunami J, Kawasaki M, Hara N.
    Cancer J Sci Am; 1996 May 28; 2(4):212-6. PubMed ID: 9166534
    [Abstract] [Full Text] [Related]

  • 38. Growth inhibition of human lymphoma cell lines by the marine products, dolastatins 10 and 15.
    Beckwith M, Urba WJ, Longo DL.
    J Natl Cancer Inst; 1993 Mar 17; 85(6):483-8. PubMed ID: 8445676
    [Abstract] [Full Text] [Related]

  • 39. [Anticancer agents and apoptosis].
    Fukuda M, Saijo N.
    Gan To Kagaku Ryoho; 1994 Feb 17; 21(3):330-5. PubMed ID: 8109988
    [Abstract] [Full Text] [Related]

  • 40. Antitumour evaluation of dolastatins 10 and 15 and their measurement in plasma by radioimmunoassay.
    Aherne GW, Hardcastle A, Valenti M, Bryant A, Rogers P, Pettit GR, Srirangam JK, Kelland LR.
    Cancer Chemother Pharmacol; 1996 Feb 17; 38(3):225-32. PubMed ID: 8646796
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.